C-Myc ALL NHL Test Cost AED: 1050.0
Introduction
Welcome to DNA Labs UAE, a leading genetic lab specializing in various DNA tests. In this blog, we will discuss the C-Myc ALL NHL Test, its cost, symptoms, diagnosis, and other important details.
Test Details
The C-Myc ALL NHL Test is a genetics test that helps in the diagnosis and management of Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin’s Lymphoma (NHL). It involves the analysis of the MYC gene, which plays a critical role in cell growth and division. The test is performed using the FISH method.
Components
The test requires a Sodium Heparin Vacutainer (2ml) for sample collection.
Price
The cost of the C-Myc ALL NHL Test is 1050.0 AED.
Sample Condition
The test can be performed using either bone marrow or peripheral blood samples.
Report Delivery
After the sample is collected, the report will be delivered within 3-4 days.
Doctor and Test Department
The C-Myc ALL NHL Test is conducted under the supervision of an oncology doctor. The test falls under the genetics department of our lab.
Pre Test Information
A doctor’s prescription is required to undergo the C-Myc ALL NHL Test. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Understanding C-Myc in ALL and NHL
The MYC gene, which encodes the C-Myc protein, is known to be involved in the development of various cancers, including ALL and NHL. In these types of blood cancers, the MYC gene is often found to be rearranged or mutated, leading to overexpression of the C-Myc protein. This overexpression can promote uncontrolled cell growth and division, contributing to the development and progression of the disease.
Potential Therapeutic Target
Due to its important role in cancer development, C-Myc has been extensively studied as a potential therapeutic target. Researchers are investigating various strategies to inhibit or disrupt C-Myc activity in order to develop more effective treatments for ALL, NHL, and other cancers associated with MYC gene abnormalities.
Conclusion
The C-Myc ALL NHL Test offered by DNA Labs UAE is a valuable tool in the diagnosis and management of Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin’s Lymphoma (NHL). It provides crucial information about the MYC gene and the overexpression of the C-Myc protein, helping doctors in designing appropriate treatment plans for patients. If you suspect any symptoms or have concerns about these types of blood cancers, we recommend consulting with an oncology doctor and considering the C-Myc ALL NHL Test.
| Test Name | C-Myc ALL NHL Test |
|---|---|
| Components | Sodium Heparin Vacutainer (2ml) |
| Price | 1050.0 AED |
| Sample Condition | Bone Marrow \/ Peripheral blood |
| Report Delivery | 3-4 days |
| Method | FISH |
| Test type | Genetics |
| Doctor | Oncology |
| Test Department: | |
| Pre Test Information | C-Myc (ALL, NHL) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
| Test Details | C-Myc is a protein that plays a critical role in cell growth and division. It is encoded by the MYC gene, which is known to be involved in the development of various cancers, including Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin’s Lymphoma (NHL). In ALL, a type of blood cancer, the MYC gene is often found to be rearranged or mutated, leading to overexpression of the C-Myc protein. This overexpression can promote uncontrolled cell growth and division, contributing to the development and progression of the disease. Similarly, in NHL, which is a group of lymphoid malignancies, abnormalities in the MYC gene can lead to increased expression of C-Myc. This dysregulation of C-Myc can drive the growth and survival of lymphoma cells, making it a potential target for therapeutic interventions. Due to its important role in cancer development, C-Myc has been extensively studied as a potential therapeutic target. Researchers are investigating various strategies to inhibit or disrupt C-Myc activity in order to develop more effective treatments for ALL, NHL, and other cancers associated with MYC gene abnormalities. |
